NASDAQ$BTTC

Black Titan Corp · Q4 2018 earnings

Q4 2018 earnings · Reported Apr 1, 2019 (7 years ago) · Investor relations

Apr 1Dec 31, 2018

Total Revenue

$1.24M

Previous: $58K+2032.8%

EPS (adj)

-$372.00

Previous: -$612.00+39.2%

Capital Expenditures

$345K

Previous: $20K+1625.0%

Free Cash Flow

-$3.65M

Previous: -$3.88M+5.9%

Net Income

-$3.5M

Previous: -$3.66M+4.3%

Operating Income

-$3.27M

Previous: -$3.37M+3.2%

Gross Profit

$240K

Previous: -$2.25M+110.7%

Cash & Equivalents

$9.3M

Previous: $7.52M+23.6%

Total Assets

$14.1M

Previous: $8.91M+58.3%

Stock-Based Comp

$335K

Previous: $480K-30.2%

Titan Pharmaceuticals · Revenue · Quarterly

$1.24M

Q4 2018+2,032.8%vs Q4 2017

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation